Seelos Therapeutics, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
10-K/A: Seelos Therapeutics Files Amended 10-K Report, Disclosing Key Governance and Compensation Details
Seelos Therapeutics has filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and related matters.
OTC.Pink
Seelos Therapeutics details its capital structure, outstanding warrants, convertible notes, and anti-takeover provisions in a recent SEC filing.